IRCCS Istituto Ortopedico Galeazzi Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2018
NCT04078880
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

IRCCS Istituto Ortopedico Galeazzi | IRCSS Istituto Ortopedico Galeazzi | istituto galeazzi

Active Ingredients

Drugs in Other Trials (2)

iron (1 trial)

vitamin c (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2